Oman, the historic and strategically positioned nation at the confluence of the Gulf and the Arabian Peninsula, boasts a vibrant pharmaceutical industry that has been thriving in recent years. In this comprehensive article, we will delve into the captivating history, key players, and promising future prospects of the pharmaceutical landscape in Oman. Oman’s Historical Tapestry […]
In recent years, the world has witnessed the devastating impact of the COVID-19 pandemic, which originated in Wuhan, China. While the origins of the virus have been a subject of debate and investigation, one prominent virologist, Chinese scientist Shi Zhengli, often referred to as “Batwoman” due to her extensive research on viruses originating from animals, […]
Management of mild to moderate COVID-19 during the wave in India; Doctor Believes Ivermectin Drug Can Help With COVID-19 taking a tight grasp on the lives of people in India and around the world, experts have been tirelessly searching for existing medications that can help combat this relentless virus. While vaccines like Pfizer, Moderna, and […]
New Covid variant Eris symptoms appear a week before positive test? Know all about this ‘pre-Covid’ phenomenon In the ever-evolving landscape of the COVID-19 pandemic, new variants continue to emerge, each with its own set of characteristics and challenges. Among the latest variants to capture attention is the Eris variant, specifically EG.5. This variant has […]
The NHS has embarked on an urgent mission to administer booster shots of Covid and flu vaccines to older residents in care homes across England. This accelerated rollout, set to commence on Monday, aims to swiftly bolster the immunity of those who are at the highest risk due to the emergence of a highly-mutated new […]
Ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and an 86% reduction in the risk of dying from a COVID-19 infection BY WILL JONES 3 SEPTEMBER 2022 5:55 PM Regular use of ivermectin led to a 100% reduction in hospitalisation rate, a 92% reduction in mortality rate and […]
Pharmaceutical firm Taj Pharma has announced that it has introduced Covid-19 treatment drug Molnupiravir under brand name “Molnutaj” in India. Molnupiravir is for treatment of adult patients hospitalised with COVID-19, under certain conditions, drug maker said.
Meta-analysis finds some ivermectin benefits in COVID-19 patient An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. […]
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM […]
A new peer-reviewed study by Dr Pierre Kory and colleagues on Ivermectin has been published in the American Journal of Therapeutics. Entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19“, it provides a new authoritative overview of the evidence to date and calls for the widely […]